SDCCAG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.543960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.048400E-01
Normal-vs-Stage2
1.378410E-01
Normal-vs-Stage3
1.364770E-01
Normal-vs-Stage4
8.323400E-01
Stage1-vs-Stage2
7.274400E-01
Stage1-vs-Stage3
1.968380E-01
Stage1-vs-Stage4
4.493000E-01
Stage2-vs-Stage3
3.309400E-01
Stage2-vs-Stage4
2.064000E-01
Stage3-vs-Stage4
1.779230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.721560E-01
Normal-vs-AfricanAmerican
2.103000E-01
Normal-vs-Asian
1.175180E-01
Caucasian-vs-AfricanAmerican
6.156200E-01
Caucasian-vs-Asian
2.504000E-01
AfricanAmerican-vs-Asian
7.618400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.500600E-01
Normal-vs-Female
1.846210E-01
Male-vs-Female
6.844200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.243400E-01
Normal-vs-Age(41-60Yrs)
4.049000E-01
Normal-vs-Age(61-80Yrs)
8.992100E-02
Normal-vs-Age(81-100Yrs)
1.648960E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.361600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.285200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.543800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.135300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.550600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.925200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.955700E-02
Normal-vs-Daily Drinker
1.302190E-01
Normal-vs-Weekly Drinker
1.520620E-01
Normal-vs-Occasional Drinker
4.444600E-01
Normal-vs-Social Drinker
1.667770E-01
Non Drinker-vs-Daily Drinker
9.733400E-01
Non Drinker-vs-Weekly Drinker
8.336600E-01
Non Drinker-vs-Occasional Drinker
1.047200E-01
Non Drinker-vs-Social Drinker
6.682400E-01
Daily Drinker-vs-Weekly Drinker
8.729600E-01
Daily Drinker-vs-Occasional Drinker
1.447240E-01
Daily Drinker-vs-Social Drinker
6.842800E-01
Weekly Drinker-vs-Occasional Drinker
1.594570E-01
Weekly Drinker-vs-Social Drinker
6.079800E-01
Occasional Drinker-vs-Social Drinker
3.096600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.513700E-02
Normal-vs-Grade 2
7.817200E-03
Normal-vs-Grade 3
1.252340E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.954200E-01
Grade 1-vs-Grade 3
5.617200E-01
Grade 1-vs-Grade 4
6.513700E-02
Grade 2-vs-Grade 3
2.710800E-01
Grade 2-vs-Grade 4
7.817200E-03
Grade 3-vs-Grade 4
1.252340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.761600E-02
Normal-vs-NonDiabetic
1.211210E-01
Diabetic-vs-NonDiabetic
4.115400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.810000E-02
Normal-vs-NoPancreatitis
1.262230E-01
Pancreatitis-vs-NoPancreatitis
4.750400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.138200E-01
Normal-vs-N1
1.362360E-01
N0-vs-N1
6.826800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.080000E-01
Normal-vs-TP53-NonMutant
3.572200E-01
TP53-Mutant-vs-TP53-NonMutant
9.822200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
